GARDASIL 9
These highlights do not include all the information needed to use GARDASIL 9 safely and effectively. See full prescribing information for GARDASIL 9. GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 2014
a21f4f4b-b891-4f25-b747-cb9ec7d865d6
VACCINE LABEL
Mar 25, 2025
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Human Papillomavirus 9-valent Vaccine, Recombinant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Human Papillomavirus 9-valent Vaccine, Recombinant
Product Details
FDA regulatory identification and product classification information